|
Coagulation inhibitors
Citations 1-10 of 41 total displayed.
|
Most recent content
(16 Sep 2008):
|
- Editorials
What to Do With Patients Receiving Long-Term Clopidogrel: Reload or Relax?
- David O. Williams and J. Dawn Abbott
Circulation 2008; 118: 1219-1222, doi:10.1161/CIRCULATIONAHA.108.804229
[Full text]
|
Past content
(since Apr 2001):
|
- Coronary Heart Disease
Phase 1b Randomized Study of Antidote-Controlled Modulation of Factor IXa Activity in Patients With Stable Coronary Artery Disease
- Mark Y. Chan, Mauricio G. Cohen, Christopher K. Dyke, Shelley K. Myles, Laura G. Aberle, Min Lin, James Walder, Steven R. Steinhubl, Ian C. Gilchrist, Neal S. Kleiman, David A. Vorchheimer, Nicholas Chronos, Chiara Melloni, John H. Alexander, Robert A. Harrington, Ross M. Tonkens, Richard C. Becker, and Christopher P. Rusconi
Circulation 117: 2865 -2874; published online before print as doi:10.1161/CIRCULATIONAHA.107.745687
[Abstract]
[Full text]
- Articles
Phase 1b Randomized Study of Antidote-Controlled Modulation of Factor IXa Activity in Patients With Stable Coronary Artery Disease
- Mark Y. Chan, Mauricio G. Cohen, Christopher K. Dyke, Shelley K. Myles, Laura G. Aberle, Min Lin, James Walder, Steven R. Steinhubl, Ian C. Gilchrist, Neal S. Kleiman, David A. Vorchheimer, Nicholas Chronos, Chiara Melloni, John H. Alexander, Robert A. Harrington, Ross M. Tonkens, Richard C. Becker, and Christopher P. Rusconi
Circulation published May 27, 2008, doi:10.1161/CIRCULATIONAHA.107.745687
[Abstract]
- Coronary Heart Disease
Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention: The Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation–Thrombolysis in Myocardial Infarction 44 Trial
- Stephen D. Wiviott, Dietmar Trenk, Andrew L. Frelinger, Michelle O’Donoghue, Franz-Josef Neumann, Alan D. Michelson, Dominick J. Angiolillo, Hanoch Hod, Gilles Montalescot, Debra L. Miller, Joseph A. Jakubowski, Richard Cairns, Sabina A. Murphy, Carolyn H. McCabe, Elliott M. Antman, Eugene Braunwald for the PRINCIPLE-TIMI 44 Investigators
Circulation 116: 2923 -2932; published online before print as doi:10.1161/CIRCULATIONAHA.107.740324
[Abstract]
[Full text]
- Articles
Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention. The Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation–Thrombolysis in Myocardial Infarction 44 Trial
- Stephen D. Wiviott, Dietmar Trenk, Andrew L. Frelinger, Michelle O'Donoghue, Franz-Josef Neumann, Alan D. Michelson, Dominick J. Angiolillo, Hanoch Hod, Gilles Montalescot, Debra L. Miller, Joseph A. Jakubowski, Richard Cairns, Sabina A. Murphy, Carolyn H. McCabe, Elliott M. Antman, Eugene Braunwald for the PRINCIPLE-TIMI 44 Investigators
Circulation published December 3, 2007, doi:10.1161/CIRCULATIONAHA.107.740324
[Abstract]
- Editorials
A Replacement for Warfarin: The Search Continues
- John W. Eikelboom and Jeffrey I. Weitz
Circulation 116: 131 -133; published online before print as doi:10.1161/CIRCULATIONAHA.107.712349
[Full text]
- Vascular Medicine
Treatment of Proximal Deep-Vein Thrombosis With the Oral Direct Factor Xa Inhibitor Rivaroxaban (BAY 59-7939): The ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) Study
- Giancarlo Agnelli, Alexander Gallus, Samuel Z. Goldhaber, Sylvia Haas, Menno V. Huisman, Russel D. Hull, Ajay K. Kakkar, Frank Misselwitz, Sebastian Schellong for the ODIXa-DVT Study Investigators
Circulation 116: 180 -187; published online before print as doi:10.1161/CIRCULATIONAHA.106.668020
[Abstract]
[Full text]
- Articles
A Replacement for Warfarin. The Search Continues
- John W. Eikelboom and Jeffrey I. Weitz
Circulation published June 18, 2007, doi:10.1161/CIRCULATIONAHA.107.712349
[Abstract]
- Articles
Treatment of Proximal Deep-Vein Thrombosis With the Oral Direct Factor Xa Inhibitor Rivaroxaban (BAY 59-7939). The ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) Study
- Giancarlo Agnelli, Alexander Gallus, Samuel Z. Goldhaber, Sylvia Haas, Menno V. Huisman, Russel D. Hull, Ajay K. Kakkar, Frank Misselwitz, Sebastian Schellong for the ODIXa-DVT Study Investigators
Circulation published June 18, 2007, doi:10.1161/CIRCULATIONAHA.106.668020
[Abstract]
- Stroke
Targeting Platelets in Acute Experimental Stroke: Impact of Glycoprotein Ib, VI, and IIb/IIIa Blockade on Infarct Size, Functional Outcome, and Intracranial Bleeding
- Christoph Kleinschnitz, Miroslava Pozgajova, Mirko Pham, Martin Bendszus, Bernhard Nieswandt, and Guido Stoll
Circulation 115: 2323 -2330; published online before print as doi:10.1161/CIRCULATIONAHA.107.691279
[Abstract]
[Full text]
|
|
